Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients
- PMID: 26327706
- PMCID: PMC4552233
- DOI: 10.4212/cjhp.v68i4.1472
Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients
Abstract
Background: Many health care institutions are in the process of establishing antimicrobial stewardship programs. Changing the route of administration of antimicrobial agents from intravenous to oral (IV to PO) is a simple, well-recognized intervention that is often part of an antimicrobial stewardship program. However, the attending health care team may have concerns about making this switch.
Objectives: To provide insights into common concerns related to IV to PO conversion, with the aim of helping antimicrobial stewardship teams to address them.
Data sources: Published clinical trials and reviews were identified from a literature search of Ovid MEDLINE with the keywords (step down or switch or conversion or transition or sequential) and (antibiotics or antibacterial agents or antimicrobial or anti-infective agents).
Data synthesis: The following issues are addressed in this review: benefits of the oral route, serum concentrations yielded by the oral formulation, source of pharmacokinetic data, clinical outcomes, provision of care in the intensive care unit, fear of therapeutic failure, and administration of antimicrobials via feeding tube.
Conclusions: When considering a change to oral therapy, it is important to have a thorough understanding of key aspects of the antimicrobial agent, the patient, and the disease being treated. The antimicrobial stewardship team has an important role in facilitating IV to PO conversion, educating prescribers, and addressing any concerns or reservations that may interfere with timely transition from IV to PO administration.
Contexte: Bon nombre d’établissements de santé sont en voie de mettre en place de programmes de gestion responsable des antimicrobiens. Changer de voie d’administration des agents antimicrobiens en passant d’une administration intraveineuse à une administration orale est une intervention simple et reconnue qui fait souvent partie de ces programmes. Cependant, opérer un tel changement pourrait soulever des préoccupations chez les membres de l’équipe de soins de santé traitante.
Objectifs: Dégager une meilleure compréhension des préoccupations courantes entourant le passage de la voie d’administration intraveineuse à la voie d’administration orale dans le but d’aider les équipes de gestion responsable des antimicrobiens à y répondre.
Sources des données: Des analyses documentaires ainsi que des essais cliniques publiés ont été recensés grâce à une recherche dans Ovid MEDLINE à l’aide des mots clés (step down [passage] ou switch [échange] ou conversion [conversion] ou transition [transition] ou sequential [successif]) et (antibiotics [antibiotiques]) ou antibacterial agents [agents antibactériens] ou antimicrobial [antimicrobien] ou anti-infective agents [agents anti-infectieux]).
Synthèse des données: Les préoccupations suivantes sont abordées dans la présente analyse : les avantages de la voie orale, les concentrations sériques obtenues grâce aux préparations orales, la source des données pharmacocinétiques, les résultats cliniques, la prestation des soins à l’unité des soins intensifs, la peur de l’échec thérapeutique et l’administration des antimicrobiens par sonde gastrique.
Conclusions: Lorsque l’on envisage de passer à un traitement par voie orale, il est important de posséder une connaissance approfondie des principaux aspects de l’agent antimicrobien, de l’état du patient et de la maladie traitée. L’équipe de gestion responsable des antimicrobiens détient un rôle important pour ce qui est de simplifier le passage d’une administration intraveineuse à une administration orale, d’éduquer les prescripteurs et de répondre aux préoccupations et doutes qui pourraient faire obstacle à un tel passage en temps voulu.
Keywords: IV to PO transition; antimicrobial stewardship programs; antimicrobials; intravenous therapy; oral therapy; step-down.
Similar articles
-
The use of an IV to PO clinical intervention form to improve antibiotic administration in a community based hospital.BMJ Qual Improv Rep. 2015 Jan 28;4(1):u200786.w2247. doi: 10.1136/bmjquality.u200786.w2247. eCollection 2015. BMJ Qual Improv Rep. 2015. PMID: 26734367 Free PMC article.
-
Impact of printed antimicrobial stewardship recommendations on early intravenous to oral antibiotics switch practice in district hospitals.Pharm Pract (Granada). 2018 Apr-Jun;16(2):855. doi: 10.18549/PharmPract.2018.02.855. Epub 2018 Jun 17. Pharm Pract (Granada). 2018. PMID: 30023021 Free PMC article.
-
Comparison of the impact of a system tele-antimicrobial stewardship program on the conversion of intravenous-to-oral antimicrobials in community hospitals.Antimicrob Steward Healthc Epidemiol. 2024 Oct 2;4(1):e159. doi: 10.1017/ash.2024.423. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 39371437 Free PMC article.
-
Implementing criteria-based early switch/early discharge programmes: a European perspective.Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S47-55. doi: 10.1016/j.cmi.2015.03.023. Epub 2015 Jul 18. Clin Microbiol Infect. 2015. PMID: 26198369 Review.
-
Antimicrobial stewardship programs in health care systems.Clin Microbiol Rev. 2005 Oct;18(4):638-56. doi: 10.1128/CMR.18.4.638-656.2005. Clin Microbiol Rev. 2005. PMID: 16223951 Free PMC article. Review.
Cited by
-
In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program.J Antimicrob Chemother. 2023 Jun 1;78(6):1406-1414. doi: 10.1093/jac/dkad099. J Antimicrob Chemother. 2023. PMID: 37042351 Free PMC article.
-
Transitioning to oral therapy compared to IV in Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.Ann Med Surg (Lond). 2025 Jan 9;87(1):265-275. doi: 10.1097/MS9.0000000000002742. eCollection 2025 Jan. Ann Med Surg (Lond). 2025. PMID: 40109636 Free PMC article.
-
Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers.Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0162322. doi: 10.1128/aac.01623-22. Epub 2023 Mar 29. Antimicrob Agents Chemother. 2023. PMID: 36988461 Free PMC article. Clinical Trial.
-
Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice.Tuberculosis (Edinb). 2022 Dec;137:102268. doi: 10.1016/j.tube.2022.102268. Epub 2022 Oct 4. Tuberculosis (Edinb). 2022. PMID: 36228452 Free PMC article.
-
Post-traumatic endophthalmitis prophylaxis: a systematic review and meta-analysis.J Ophthalmic Inflamm Infect. 2022 Nov 18;12(1):39. doi: 10.1186/s12348-022-00317-y. J Ophthalmic Inflamm Infect. 2022. PMID: 36396863 Free PMC article.
References
-
- Kuper K. Intravenous to oral therapy conversion. In: Murdaugh LB, editor. Competence assessment tools for health-system pharmacies. 4th ed. Bethesda (MD): American Society of Health-System Pharmacists; 2008. pp. 347–60.
-
- Burgess D. Antimicrobial regimen selection. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy a pathophysiological approach. 8th ed. Toronto (ON): The McGraw-Hills Companies; 2011. pp. 1813–23.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources